se of Modified frailty Index (mFi) for prediction of postoperative complications in patients undergoing Cytoreductive surgery with Hyperthermic Intraperitoneal Chemotherapy
Not Applicable
- Conditions
- Health Condition 1: C260- Malignant neoplasm of intestinal tract, part unspecified
- Registration Number
- CTRI/2021/05/033669
- Lead Sponsor
- Dr Malini Joshi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients above 18 years who underwent Cytoreductive surgeries with Hyperthermic Intraperitoneal Chemotherapy under general anesthesia
Exclusion Criteria
Paediatric patients
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Major post operative complications (clavien dindo class 3-4) within 30 post operative daysTimepoint: Date of surgery to 30 days post operative period
- Secondary Outcome Measures
Name Time Method 1. Mortality <br/ ><br>2. Need for vasopressin <br/ ><br>3. Need and duration of postop ventilation <br/ ><br>4. Any other organ support <br/ ><br>5. ICU length of stay <br/ ><br>6. Hospital length of stay <br/ ><br>7. Hospital outcomeTimepoint: Date of surgery to 30 days postoperative period